261 related articles for article (PubMed ID: 32410515)
1. Optimized diagnosis of
Cho JH; Jin SY
Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):553-564. PubMed ID: 32410515
[TBL] [Abstract][Full Text] [Related]
2. Multicentric randomised study of
Leja M; Park JY; Murillo R; Liepniece-Karele I; Isajevs S; Kikuste I; Rudzite D; Krike P; Parshutin S; Polaka I; Kirsners A; Santare D; Folkmanis V; Daugule I; Plummer M; Herrero R
BMJ Open; 2017 Aug; 7(8):e016999. PubMed ID: 28801429
[TBL] [Abstract][Full Text] [Related]
3. Screening and eradication of
Liou JM; Malfertheiner P; Lee YC; Sheu BS; Sugano K; Cheng HC; Yeoh KG; Hsu PI; Goh KL; Mahachai V; Gotoda T; Chang WL; Chen MJ; Chiang TH; Chen CC; Wu CY; Leow AH; Wu JY; Wu DC; Hong TC; Lu H; Yamaoka Y; Megraud F; Chan FKL; Sung JJ; Lin JT; Graham DY; Wu MS; El-Omar EM;
Gut; 2020 Dec; 69(12):2093-2112. PubMed ID: 33004546
[TBL] [Abstract][Full Text] [Related]
4. Population based Helicobacter pylori screening and eradication: advances versus side effects.
Tepes B
Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
[TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
[TBL] [Abstract][Full Text] [Related]
6. Metachronous gastric cancer after successful Helicobacter pylori eradication.
Shiotani A; Haruma K; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors associated with recovery of the serum pepsinogen ratio after
Cho JH; Jeon SR; Jin SY; Park S
Scand J Gastroenterol; 2019 Nov; 54(11):1306-1314. PubMed ID: 31702966
[No Abstract] [Full Text] [Related]
9. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat.
Suzuki H; Mori H
J Gastroenterol; 2018 Mar; 53(3):354-361. PubMed ID: 29138921
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
11. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
12. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
[TBL] [Abstract][Full Text] [Related]
13. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
[TBL] [Abstract][Full Text] [Related]
14. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
Yanaoka K; Oka M; Ohata H; Yoshimura N; Deguchi H; Mukoubayashi C; Enomoto S; Inoue I; Iguchi M; Maekita T; Ueda K; Utsunomiya H; Tamai H; Fujishiro M; Iwane M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2009 Dec; 125(11):2697-703. PubMed ID: 19610064
[TBL] [Abstract][Full Text] [Related]
17. Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.
Choi JM; Kim SG; Choi J; Park JY; Oh S; Yang HJ; Lim JH; Im JP; Kim JS; Jung HC
Gastrointest Endosc; 2018 Sep; 88(3):475-485.e2. PubMed ID: 29800546
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands.
Chiang TH; Maeda M; Yamada H; Chan CC; Chen SL; Chiu SY; Chen YN; Chou YH; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chen HH; Ushijima T; Graham DY; Lee YC
J Gastroenterol Hepatol; 2021 Mar; 36(3):671-679. PubMed ID: 32671873
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.
Asaka M; Mabe K; Matsushima R; Tsuda M
Gastroenterol Clin North Am; 2015 Sep; 44(3):639-48. PubMed ID: 26314673
[TBL] [Abstract][Full Text] [Related]
20.
MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
